Healthcare provider profile · identity verified

Suvan Sachdev, MD

Internal Medicine · FONTANA, CA · NPI 1497822233

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	660	252
Amlodipine Besylate	Amlodipine Besylate	367	144
Lisinopril	Lisinopril	309	124
Levothyroxine Sodium	Levothyroxine Sodium	293	106
Losartan Potassium	Losartan Potassium	203	90
Metformin Hcl	Metformin Hcl	190	70
Metformin Hcl Er	Metformin Hcl	189	73
Rosuvastatin Calcium	Rosuvastatin Calcium	188	79
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	181	52
Gabapentin	Gabapentin	166	58
Glipizide	Glipizide	152	61
Omeprazole	Omeprazole	146	63
Trazodone Hcl	Trazodone Hcl	137	41
Furosemide	Furosemide	128	52
Tamsulosin Hcl	Tamsulosin Hcl	128	51
Albuterol Sulfate Hfa	Albuterol Sulfate	124	60
Simvastatin	Simvastatin	122	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	120	47
Meloxicam	Meloxicam	108	46
Metoprolol Tartrate	Metoprolol Tartrate	108	48
Atenolol	Atenolol	107	44
Alendronate Sodium	Alendronate Sodium	105	41
Potassium Chloride	Potassium Chloride	103	39
Ozempic	Semaglutide	91	16
Hydrochlorothiazide	Hydrochlorothiazide	90	39
Pradaxa	Dabigatran Etexilate Mesylate	88	28
Terazosin Hcl	Terazosin Hcl	84	28
Pantoprazole Sodium	Pantoprazole Sodium	83	38
Allopurinol	Allopurinol	75	28
Clopidogrel	Clopidogrel Bisulfate	69	24
Jardiance	Empagliflozin	69	30
Valsartan	Valsartan	68	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	12
Tramadol Hcl	Tramadol Hcl	65	24
Humulin N	Insulin Nph Human Isophane	63	28
Prednisone	Prednisone	62	46
Triamcinolone Acetonide	Triamcinolone Acetonide	60	29
Finasteride	Finasteride	56	20
Temazepam	Temazepam	56	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	55	28
Hydralazine Hcl	Hydralazine Hcl	54	21
Azelastine Hcl	Azelastine Hcl	52	16
Carvedilol	Carvedilol	52	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	18
Bisoprolol Fumarate	Bisoprolol Fumarate	50	22
Lorazepam	Lorazepam	49	14
Glipizide Er	Glipizide	48	20
Metoprolol Succinate	Metoprolol Succinate	45	17
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	45	19
Montelukast Sodium	Montelukast Sodium	44	19
Alprazolam	Alprazolam	42	suppressed
Duloxetine Hcl	Duloxetine Hcl	42	13
Famotidine	Famotidine	39	18
Fluticasone Propionate	Fluticasone Propionate	39	11
Ibuprofen	Ibuprofen	38	23
Azithromycin	Azithromycin	37	34
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Humulin N Kwikpen	Insulin Nph Human Isophane	35	15
Wixela Inhub	Fluticasone Propion/Salmeterol	35	12
Nitroglycerin	Nitroglycerin	34	19
Victoza 2-Pak	Liraglutide	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	11
Ezetimibe	Ezetimibe	31	suppressed
Alvesco	Ciclesonide	29	16
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Nystatin	Nystatin	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	13
Terbinafine Hcl	Terbinafine Hcl	27	18
Fenofibrate	Fenofibrate	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	15
Lactulose	Lactulose	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Cephalexin	Cephalexin	22	19
Hydrocortisone	Hydrocortisone	22	11
Colchicine	Colchicine	21	13
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Humulin R	Insulin Regular, Human	20	suppressed
Mupirocin	Mupirocin	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Trospium Chloride	Trospium Chloride	20	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Liraglutide	Liraglutide	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Amoxicillin	Amoxicillin	15	13
Bupropion Xl	Bupropion Hcl	15	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Baclofen	Baclofen	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Diazepam	Diazepam	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error